glucose

Graphic image of a red ball navigating a maze

Biotech

Sanofi to enter Maze deal with $750M pact for Pompe med

Sanofi is betting up to $750 million to license a phase 2-ready treatment for Pompe disease from Maze Therapeutics.

Max Bayer May 1, 2023 6:00am

iGlucose System

Smart Meter’s connected glucose tracker picks up U.S., EU nods

May 16, 2017 4:26pm

Insulia

Voluntis scores U.S., EU nods for Type 2 diabetes software

Dec 6, 2016 12:09pm